RECENT RESEARCH STUDIES:
- Invega Phase IV in the treatment of Adults with Schizophrenia (Closed)
- Duloxetine Phase II, Major Depression Children and Adolescent Age 7 to 17.(Not Recruiting)
- Ziprazidone Phase III, as Adjunt treatment of Bipolar I Disorder Depressed, in Patients treated with Depakote, Tegretol or Lamictal. (Recruiting)
- Pfizer Phase II, Sleep Medicine, New Compound, for patients with good general health, and daytime sleepiness. (Recruiting)
- Otsuka Pharmaceuticals, Aripiprazole IM long acting (monthly injections) in patients with Schizopphhrenia (Recruiting starts early August 2008)
PRINCIPAL INVESTIGATOR'S:
DR. RANDALL RICARDI, DO
DR. LAURO AMEZCUA-PATINO, MD, FAPA
SUB-INVESTIGATOR:
DR. MEHMUD AHMED, MD
CLINICAL RATERS:
BRENNON JONES, PA
NURSING STAFF:
DOREEN GRIBBLE. LPN
BRENDA TRAUTMAN, RN
RESEARCH COORDINATOR:
BARBARA WILSON
CONTACT: 480-464-4431 x305 INFO@STUDYCLINIC.NET